• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    What It Means For US Stocks To Be In A Bear Market

    6/22/22 2:27:51 PM ET
    $ABT
    $ANTM
    $BDX
    $CMCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities
    Health Care
    Get the next $ABT alert in real time by email

    Wall Street has officially fallen into a bear market as investor sentiment is hammered by soaring inflation, rising interest rates and worries about a looming recession in the world’s largest economy. 

    A bear market occurs when a stock index like the S&P 500 falls by 20% over a sustained period from a recent high. Conversely, a bull market happens when stocks rise 20% from a recent low. 

    On June 13, the S&P closed in bear market territory for the first time since March 2020, as it slipped 3.9% to 3,749.63, its lowest since March 2020, and the second bear market of the pandemic era. The S&P sank deeper on Thursday, June 16, to close at a new low since December 2020.  

    2020 market crash 

    The last time that US stocks entered a bear market was in March 2020 at a time when many nations implemented lockdowns to prevent the spread of COVID-19 cases. That period marked the first time in 11 years that the Dow Jones Industrial Average entered a bear market, with the S&P 500 and the Nasdaq following suit.  

    Stocks shed a third of their value in 33 days at the time, according to data compiled by Ed Yardeni, an economist who tracks stock swings. It took six months for the S&P to recover, helped by government stimulus and policy actions by the Federal Reserve, according to The New York Times. 

    Not a bug in the system 

    During bear markets, investors — of stocks, cryptocurrencies, and 401k plans — become more anxious and make the common mistake of liquidating their assets over fears that a rebound would be unlikely.  

    While fear of losses are understandable, investors should know that bear markets, crashes and corrections are inevitable and are all a feature of financial markets and not a bug in the system.  

    There have been 14 bear markets since the World War II, including the current one, and recoveries take 23 months on average, The Washington Post reported last week, citing Sam Stovall, chief investment strategist at CFRA. 

    "These things have to happen every once and a while for the system to function properly and wash out the excesses,” fund manager Ben Carlson said in his book called A Wealth of Common Sense. Carlson said investors have to mentally prepare themselves for dealing with losses. 

    Enduring bear markets 

    Long-term investors, such as those who ought to keep their investments for retirement purposes, may take advantage of the current bear market to buy the dip as stocks tend to offer strong returns in the long run. 

    Morgan Stanley last month released a list of some high-quality stocks to buy to weather the bear market. 

    The list includes Abbott Laboratories (NYSE:ABT), The Coca-Cola Co. (NYSE:KO), Linde plc (NYSE:LIN), Becton, Dickinson and Company (NYSE:BDX), Johnson Controls International plc (NYSE:JCI), Anthem Inc. (NYSE:ANTM), The Procter & Gamble Company (NYSE:PG), Comcast Corp. (NASDAQ:CMCSA), Exxon Mobil Corp. (NYSE:XOM), and Mastercard Inc. (NYSE:MA). 

    The bank kept an Overweight rating on all these stocks. 

    However, dip buyers should not fall victim to temporary bear market rallies. Rallies in the middle of bear markets are common. 

    Divesting stocks during a bear market is also common as it helps investors stem further losses, although the move could prevent them from recouping losses and cashing in on future gains.  

    Chad Langager, co-founder of Second Summit Ventures, suggests diversifying portfolios between a variety of asset classes, not just the stock market.  

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $ANTM
    $BDX
    $CMCSA

    CompanyDatePrice TargetRatingAnalyst
    Procter & Gamble Company
    $PG
    2/18/2026Hold → Buy
    Erste Group
    Linde plc
    $LIN
    2/10/2026$460.00Buy → Hold
    DZ Bank
    Becton Dickinson and Company
    $BDX
    2/10/2026$202.00Overweight
    Barclays
    Linde plc
    $LIN
    2/6/2026$455.00Overweight → Neutral
    Analyst
    Mastercard Incorporated
    $MA
    2/3/2026$610.00Neutral → Outperform
    Daiwa Securities
    Becton Dickinson and Company
    $BDX
    2/3/2026$233.00Buy
    Citigroup
    Exxon Mobil Corporation
    $XOM
    2/3/2026$125.00Neutral → Underperform
    BNP Paribas Exane
    Exxon Mobil Corporation
    $XOM
    2/3/2026$135.00 → $145.00Buy
    TD Cowen
    More analyst ratings

    $ABT
    $ANTM
    $BDX
    $CMCSA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Starks Daniel J bought $1,087,331 worth of Common shares without par value (10,000 units at $108.73), increasing direct ownership by 0.15% to 6,738,817 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    2/6/26 8:04:16 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Vergnano Mark bought $1,011,320 worth of Ordinary Shares (7,665 units at $131.94), gifted 7,665 units of Ordinary Shares and received a gift of 7,665 units of Ordinary Shares (SEC Form 4)

    4 - Johnson Controls International plc (0000833444) (Issuer)

    2/5/26 6:32:15 PM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ANTM
    $BDX
    $CMCSA
    SEC Filings

    View All

    SEC Form 144 filed by Johnson Controls International plc

    144 - Johnson Controls International plc (0000833444) (Subject)

    2/23/26 4:10:44 PM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    SEC Form 424B3 filed by Abbott Laboratories

    424B3 - ABBOTT LABORATORIES (0000001800) (Filer)

    2/23/26 9:31:03 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3ASR filed by Abbott Laboratories

    S-3ASR - ABBOTT LABORATORIES (0000001800) (Filer)

    2/23/26 8:55:31 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ANTM
    $BDX
    $CMCSA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Procter & Gamble upgraded by Erste Group

    Erste Group upgraded Procter & Gamble from Hold to Buy

    2/18/26 9:43:08 AM ET
    $PG
    Package Goods/Cosmetics
    Consumer Discretionary

    Linde plc downgraded by DZ Bank with a new price target

    DZ Bank downgraded Linde plc from Buy to Hold and set a new price target of $460.00

    2/10/26 7:59:52 AM ET
    $LIN
    Major Chemicals
    Basic Materials

    Barclays resumed coverage on Becton Dickinson with a new price target

    Barclays resumed coverage of Becton Dickinson with a rating of Overweight and set a new price target of $202.00

    2/10/26 7:21:54 AM ET
    $BDX
    Medical/Dental Instruments
    Health Care

    $ABT
    $ANTM
    $BDX
    $CMCSA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, Latin America OU Pietracci Bruno was granted 49,759 shares (SEC Form 4)

    4 - COCA COLA CO (0000021344) (Issuer)

    2/23/26 3:43:20 PM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    SVP, Chief Accounting Officer May Erin L was granted 15,855 shares, increasing direct ownership by 77% to 36,388 units (SEC Form 4)

    4 - COCA COLA CO (0000021344) (Issuer)

    2/23/26 3:40:59 PM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    Executive Vice President Chang Lisa was granted 39,807 shares, increasing direct ownership by 42% to 134,483 units (SEC Form 4)

    4 - COCA COLA CO (0000021344) (Issuer)

    2/23/26 3:38:59 PM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    $ABT
    $ANTM
    $BDX
    $CMCSA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BD to Present at Barclays 28th Annual Global Healthcare Conference

    FRANKLIN LAKES, N.J., Feb. 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 8:30 am Eastern Time. The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.About BDBD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems a

    2/23/26 4:15:00 PM ET
    $BDX
    Medical/Dental Instruments
    Health Care

    BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency

    The BD Vacutainer® Urine Complete Cup Kit preserves specimen quality, streamlines testing, and helps reduce repeat collections to support better patient careFRANKLIN LAKES, N.J., Feb. 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the launch of the BD Vacutainer® Urine Complete Cup Kit, a three-tube collection system that expands and supports broader testing capabilities from a single urine specimen. The new kit is designed to preserve sample integrity and improve workflow efficiency, while red

    2/23/26 6:50:00 AM ET
    $BDX
    Medical/Dental Instruments
    Health Care

    Exact Sciences Stockholders Approve Acquisition by Abbott

    Exact Sciences Corporation (NASDAQ:EXAS) ("Exact Sciences"), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (NYSE:ABT) at the special meeting of stockholders held earlier today. At the special meeting, preliminary results showed that more than 99% of the votes cast, representing approximately 67% of the total outstanding shares of Exact Sciences common stock as of the January 9, 2026 record date for the special meeting, were voted in favor of the transaction. Final voting results from the special meeting will be reported by Exact Sciences in a Current Report on Form 8‑

    2/20/26 4:05:00 PM ET
    $ABT
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities

    $ABT
    $ANTM
    $BDX
    $CMCSA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 23, 2021 - Coronavirus (COVID-19) Update: November 23, 2021

    For Immediate Release: November 23, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On Nov. 22, the FDA authorized three over-the-counter (OTC) COVID-19 antigen diagnostic tests for people age 14 years or older with a self-collected nasal swab sample or people age 2 years or older when an adult collects the nasal swa

    11/23/21 3:16:12 PM ET
    $BDX
    Medical/Dental Instruments
    Health Care

    July 23, 2021 - Coronavirus (COVID-19) Update: July 23, 2021

    For Immediate Release: July 23, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The agency updated its FDA COVID-19 Response At-A-Glance Summary, which provides a quick look at facts, figures and highlights on the FDA's response efforts. On Thursday, July 22 the FDA issued an Emergency Use Authorization (EUA) to Bec

    7/23/21 4:06:11 PM ET
    $BDX
    Medical/Dental Instruments
    Health Care

    $ABT
    $ANTM
    $BDX
    $CMCSA
    Financials

    Live finance-specific insights

    View All

    Abbott declares 409th consecutive quarterly dividend

    ABBOTT PARK, Ill., Feb. 20, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share. This marks the 409th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2026, to shareholders of record at the close of business on April 15, 2026.Abbott has increased its dividend payout for 54 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio o

    2/20/26 11:38:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Board of Directors of The Coca-Cola Company Elects New Officer and Approves 64th Consecutive Annual Dividend Increase

    The Board of Directors of The Coca-Cola Company today announced the election of a new company officer and the approval of the company's 64th consecutive annual dividend increase. The company is raising the quarterly dividend approximately 4% from 51 cents to 53 cents per common share. The quarterly dividend is equivalent to an annual dividend of $2.12 per share, up from $2.04 per share in 2025. The first quarter dividend is payable April 1 to shareowners of record as of March 13. The company returned $8.8 billion in dividends to shareowners in 2025, bringing the total amount of dividends paid to shareowners since Jan. 1, 2010, to $101.9 billion. Head of Investor Relations The boar

    2/19/26 2:00:00 PM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    Mastercard Board of Directors Announces Quarterly Dividend

    Company Sets Date for Annual Meeting of Stockholders Mastercard Incorporated (NYSE:MA) today announced that its Board of Directors has declared a quarterly cash dividend of 87 cents per share. The cash dividend will be paid on May 8, 2026 to holders of record of its Class A common stock and Class B common stock as of April 9, 2026. Additionally, the company announced that its annual meeting of stockholders will take place on June 16, 2026 at 8:30 a.m. Eastern Time. When filed, the definitive proxy statement will confirm the format and location of the meeting. Stockholders of record as of the close of business on April 21, 2026 will be entitled to vote. About Mastercard Incorporated (N

    2/10/26 4:10:00 PM ET
    $MA
    Real Estate

    $ABT
    $ANTM
    $BDX
    $CMCSA
    Leadership Updates

    Live Leadership Updates

    View All

    Johnson Controls signs agreement to acquire Alloy Enterprises, strengthening data center thermal management leadership

    Transaction aligned with Johnson Controls' strategy to unlock cooling innovation and accelerate the AI-based economyEnhances Johnson Controls' leading capabilities in the rapidly growing data center thermal segmentMILWAUKEE, Feb. 18, 2026 /PRNewswire/ -- Johnson Controls (NYSE:JCI), a global technology leader in energy efficiency, decarbonization, thermal management and mission-critical performance, has signed an agreement to acquire Alloy Enterprises, a Boston-based company specializing in a next-generation thermal management platform for high-performance data centers and other mission critical industrial applications. The move will expand Johnson Controls' leadership and capabilities in th

    2/18/26 4:30:00 PM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

    Announces appointment of Claire M. Fraser, Ph.D., to its Board of DirectorsForms a global life sciences and diagnostics leader focused on high-volume testing in regulated applicationsAnnounces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials SciencesMILFORD, Mass., Feb. 9, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) ("Waters") today announced it has completed the previously announced combination with the Biosciences & Diagnostic Solutions businesses of Becton, Dickinson and Company (NYSE:BDX) ("BD"). The transaction forms a global life sciences and diagnostics leader, equipped with best-in-class technologies

    2/9/26 8:40:00 AM ET
    $BDX
    $WAT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Old Spice's Most Sophisticated Cologne-Infused Scents Arrive Nationwide: Introducing the Spice Alchemist Collection

    Old Spice's New Premium Line is Crafted for Compliments with Scents Preferred Versus $300 Colognes Old Spice continues to redefine men's grooming with the Spice Alchemist collection, merging the artistry of a premium fine fragrance with cologne-infused scents and the brand's legendary, high-performance odor protection. This lineup embodies premium fragrances with scents that are preferred versus a $300 cologne in blind consumer testing, but at a fraction of the cost. Yes, you can have it all. Old Spice, the Greatest Smell in the NFL, will give fans a "sneak sniff" of Spice Alchemist at the "Unrivaled Freshness Experience" at Super Bowl LX in San Francisco, and the new lineup will continue

    2/4/26 8:06:00 AM ET
    $PG
    Package Goods/Cosmetics
    Consumer Discretionary

    $ABT
    $ANTM
    $BDX
    $CMCSA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Johnson Controls International plc

    SC 13G/A - Johnson Controls International plc (0000833444) (Subject)

    11/13/24 1:23:26 PM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Becton Dickinson and Company (Amendment)

    SC 13G/A - BECTON DICKINSON & CO (0000010795) (Subject)

    2/16/24 4:29:42 PM ET
    $BDX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Becton Dickinson and Company (Amendment)

    SC 13G/A - BECTON DICKINSON & CO (0000010795) (Subject)

    2/14/24 10:02:59 AM ET
    $BDX
    Medical/Dental Instruments
    Health Care

    $ABT
    $ANTM
    $BDX
    $CMCSA
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Exxon Mobil Corporation on Jun 20

    Director Dreyfus Maria S. bought $2,000,386 worth of shares (18,310 units at $109.25), increasing direct ownership by 105% to 35,757 units (SEC Form 4) on June 20, 2024. This substantial insider purchase is a significant development for Exxon Mobil Corporation. As we delve into the recent insider activity at Exxon Mobil, we notice a few interesting patterns. Prior to Dreyfus Maria S.'s purchase, we observed that on January 4, 2024, Ubben Jeffrey W. granted 2,500 shares, which could signal confidence in the company. On the same day, Powell Dina H. claimed no ownership of stock but was granted 8,000 shares, indicating a new ownership stake. These events suggest a mix of adjustments in holding

    6/20/24 1:39:11 PM ET
    $XOM
    Integrated oil Companies
    Energy